Comparative toxicity of silicon dioxide, silver and iron oxide nanoparticles after repeated oral administration to rats

Journal of Applied Toxicology

Volumn 35, Issue 6, 2015, Pages 681-693

  Yun, Jun Won ^a   Kim, Seung Hyun ^a   You, Ji Ran ^a   Kim, Woo Ho ^b   Jang, Ja June ^b   Min, Seung Kee ^a,b   Kim, Hee Chan ^c   Chung, Doo Hyun ^b   Jeong, Jayoung ^d   Kang, Byeong Cheol ^a,b,c   Che, Jeong Hwan ^a,c  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d National Institute of Food and Drug Safety Evaluation   (South Korea)

Author keywords

Biodistribution; Iron oxide; Nanoparticle; Silicon dioxide; Silver; Subchronic; Toxicity

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; IRON OXIDE NANOPARTICLE; NANOPARTICLE; SILICA NANOPARTICLE; SILVER NANOPARTICLE; UNCLASSIFIED DRUG; FERRIC ION; FERRIC OXIDE; METAL NANOPARTICLE; SILICON DIOXIDE; SILVER DERIVATIVE;

ACUTE TOXICITY; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; LIVER TOXICITY; LYMPHOCYTIC INFILTRATION; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TOXICITY TESTING; ANIMAL; BLOOD CELL COUNT; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; MALE; ORAL DRUG ADMINISTRATION; ORGAN SIZE; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

RATTUS;

ADMINISTRATION, ORAL; ANIMALS; BLOOD CELL COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FERRIC COMPOUNDS; MALE; METAL NANOPARTICLES; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; SILICON DIOXIDE; SILVER COMPOUNDS; TISSUE DISTRIBUTION;

EID: 84928211585     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.3125     Document Type: Article

References (68)

1. Afrooz AR, Khan IA, Hussain SM, Saleh NB. 2013. Mechanistic heteroaggregation of gold nanoparticles in a wide range of solution chemistry. Environ. Sci. Technol. 47: 1853-1860.
2. Badr Y, Abd El-Wahed MG, Mahmoud MA. 2008. Photocatalytic degradation of methyl red dye by silica nanoparticles. J. Hazard. Mater. 154: 245-253.
3. Ban M, Langonné I, Huguet N, Goutet M. 2012. Effect of submicron and nanoiron oxide particles on pulmonary immunity in mice. Toxicol. Lett. 210: 267-275.
4. Ban M, Langonné I, Huguet N, Guichard Y, Goutet M. 2013. Iron oxide particles modulate the ovalbumin-induced Th2 immune response in mice. Toxicol. Lett. 216: 31-39.
5. Bonacchi S, Genovese D, Juris R, Montalti M, Prodi L, Rampazzo E, Zaccheroni N. 2011. Luminescent silica nanoparticles: extending the frontiers of brightness. Angew. Chem. Int. Ed. Engl. 50: 4056-4066.
6. Bucci TJ, Howard PC, Tolleson WH, Laborde JB, Hansen DK. 1998. Renal effects of fumonisin mycotoxins in animals. Toxicol. Pathol. 26: 160-164.
7. Chen Y, Yin Q, Ji X, Zhang S, Chen H, Zheng Y, Sun Y, Qu H, Wang Z, Li Y, Wang X, Zhang K, Zhang L, Shi J. 2012. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells. Biomaterials 33: 7126-7137.
8. Cho WS, Cho M, Jeong J, Choi M, Han BS, Shin HS, Hong J, Chung BH, Cho MH. 2010. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol. 245: 116-123.
9. Cho WS, Duffin R, Bradley M, Megson IL, MacNee W, Lee JK, Jeong J, Donaldson K. 2013a. Predictive value of in vitro assays depends on the mechanism of toxicity of metal oxide nanoparticles. Part. Fibre Toxicol. 10: 55.
10. Cho WS, Kang BC, Lee JK, Jeong J, Che JH, Seok SH. 2013b. Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part. Fibre Toxicol. 10: 9.
11. Chun AL. 2009. Will the public swallow nanofood? Nat. Nanotechnol. 4: 790-791.
12. Dekkers S, Bouwmeester H, Bos PMJ, Peters RJB, Rietveld AG, Oomen AG. 2013. Knowledge gaps in risk assessment of nanosilica in food: evaluation of the dissolution and toxicity of different forms of silica. Nanotoxicology 7: 367-377.
13. Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJ. 2004. Nanotoxicology. Occup. Environ. Med. 61: 727-728.
14. Dong W, Sun Y, Ma Q, Zhu L, Hua W, Lu X, Zhuang G, Zhang S, Guo Z, Zhao D. 2012. Excellent photocatalytic degradation activities of ordered mesoporous anatase TiO2-SiO2 nanocomposites to various organic contaminants. J. Hazard. Mater. 229-230: 307-320.
15. Duffin R, Tran L, Brown D, Stone V, Donaldson K. 2007. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal. Toxicol. 19: 849-856.
16. EFSA. 2009. Scientific opinion on the potential risks arising from nanoscience and nanotechnologies on food and feed safety. Response to question EFSA-Q-2007-124a. EFSA J 958: 1-39. http://www.efsa.europa.eu/it/scdocs/doc/958.pdf (accessed Feb 10, 2009).
17. Eldridge JH, Hammond CJ, Meulbroek JA, Staas JK, Gilley RM, Tice TR. 1990. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Control. Release 11: 205-214.
18. Fan YO, Zhang YH, Zhang XP, Liu B, Ma YX, Jin YH. 2006. Comparative study of nanosized and microsized silica on spermatogenesis function of male rats. Wei Sheng Yan Jiu 35: 549-553.
19. Fu C, Liu T, Li L, Liu H, Chen D, Tang F. 2013. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. Biomaterials 34: 2565-2575.
20. Fubini B, Ghiazza M, Fenoglio I. 2010. Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology 4: 347-363.
21. Gamer AO, Leibold E, van Ravenzwaay B. 2006. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol. In Vitro 20: 301-307.
22. Hristozov DR, Gottardo S, Critto A, Marcomini A. 2012. Risk assessment of engineered nanomaterials: a review of available data and approaches from a regulatory perspective. Nanotoxicology 6: 880-898.
23. Jani P, Halbert GW, Langridge J, Florence AT. 1990. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J. Pharm. Pharmacol. 42: 821-826.
24. Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, Chung YH, Kwon IH, Jeong J, Han BS, Shin JH, Sung JH, Song KS, Yu IJ. 2007. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 19: 857-871.
25. Jia L. 2005. Nanoparticle formulation increases oral bioavailability of poorly soluble drugs: Approaches experimental evidences and theory. Curr. Nanosci. 1: 237-243.
26. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon IH, Jeong J, Han BS, Yu IJ. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 20: 575-583.
27. Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, Chang HK, Lee JH, Oh KH, Kelman BJ, Hwang IK, Yu IJ. 2010. Subchronic oral toxicity of silver nanoparticles. Part. Fibre Toxicol. 7: 20.
28. Korea Food and Drug Administration (KFDA). 2005. Good Laboratory Practice Regulation for Non-Clinical Laboratory Studies (notification no. 2005-79). KFDA: Osong, Korea.
29. Lee CM, Jeong HJ, Yun KN, Kim DW, Sohn MH, Lee JK, Jeong J, Lim ST. 2012. Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure. Int. J. Nanomedicine 7: 3203-3209.
30. Lee JH, Kim YS, Song KS, Ryu HR, Sung JH, Park JD, Park HM, Song NW, Shin BS, Marshak D, Ahn K, Lee JE, Yu IJ. 2013. Biopersistence of silver nanoparticles in tissues from Sprague-Dawley rats. Part. Fibre Toxicol. 10: 36.
31. Lee S, Yun HS, Kim SH. 2011. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. Biomaterials 32: 9434-9443.
32. Li JJ, Muralikrishnan S, Ng CT, Yung LY, Bay BH. 2010. Nanoparticle-induced pulmonary toxicity. Exp. Biol. Med. 235: 1025-1033.
33. Li Z, Barnes JC, Bosoy A, Stoddart JF, Zink JI. 2012. Mesoporous silica nanoparticles in biomedical applications. Chem. Soc. Rev. 41: 2590-2605.
34. 2. Asian J. Ecotoxicol. 2: 195-201.
35. Lin YS, Haynes CL. 2010. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J. Am. Chem. Soc. 132: 4834-4842.
36. Lux-Research. 2008. Nanomaterials state of the market Q3 2008: Stealth success, broad impact. Report. [Online] https://portal.luxresearchinc.com/research/document_excerpt/3735/ (accessed July 1, 2008).
37. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdorster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit DB. 2006. Safe handling of nanotechnology. Nature 444: 267-269.
38. Maynard AD, Warheit DB, Philbert MA. 2011. The new toxicology of sophisticated materials: Nanotoxicology and beyond. Toxicol. Sci. 120: S109-S129.
39. Napierska D, Thomassen LC, Rabolli V, Lison D, Gonzalez L, Kirsch-Volders M, Martens JA, Hoet PH. 2009. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 5: 846-853.
40. Nel A, Xia T, Mädler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311: 622-627.
41. NSET. 2010. The National Nanotechnology Initiative. Research and Development Leading to a Revolution in Technology and Industry Supplement to the Present's FY 2011 Budget. Subcommittee on nanoscale Science, Engineering and Technology, Committee on Technology, National Science and Technology Council, Washington, DC, 1-65.
42. OECD. 1998. OECD guideline for testing of chemicals, Test No.408: Repeated dose 90-day oral toxicity study in rodents. OECD: Paris, France.
43. OECD. 2001. OECD guideline for testing of chemicals, Test No.420: Acute oral toxicity - Fixed dose procedure. OECD: Paris, France.
44. Rashidi L, Khosravi-Darani K. 2011. The applications of nanotechnology in food industry. Crit. Rev. Food Sci. Nutr. 51: 723-730.
45. Saxena A, Srivastava AK, Singh B, Goyal A. 2012. Removal of sulphur mustard, sarin and simulants on impregnated silica nanoparticles. J. Hazard. Mater. 211-212: 226-232.
46. SCENIHR. 2014. Nanosilver: Safety, Health and Environmental Effects and Role in Antimicrobial Resistance. Scientific Committee on Emerging and Newly Identified Health Risks. Luxembourg: European Commission, SANCO, Health & Consumers - Directorate C: Public Health.
47. Schneider M, Stracke F, Hansen S, Schaefer UF. 2009. Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinology 1: 197-206.
48. Schramlová J, Blazek K, Bartácková M, Otová B, Mardesicová L, Zizkovský V, Hulínská D. 1997. Electron microscopic demonstration of the penetration of liposomes through skin. Folia Biol (Praha). 43: 165-169.
49. Seok SH, Cho WS, Park JS, Na Y, Jang A, Kim H, Cho Y, Kim T, You JR, Ko S, Kang BC, Lee JK, Jeong J, Che JH. 2013. Rat pancreatitis produced by 13-week administration of zinc oxide nanoparticles: biopersistence of nanoparticles and possible solutions. J. Appl. Toxicol. 33: 1089-1096.
50. Shiohara A, Hanada S, Prabakar S, Fujioka K, Lim TH, Yamamoto K, Northcote PT, Tilley RD. 2010. Chemical reactions on surface molecules attached to silicon quantum dots. J. Am. Chem. Soc. 132: 248-253.
51. Shull RM, Stowe CM, Osborne CA, O'Leary TP, Vernier RL, Hammer RF. 1981. Membranous glomerulonephropathy and nephrotic syndrome associated with iatrogenic metallic mercury poisoning in a cat. Vet. Hum. Toxicol. 23: 1-5.
52. Sigfridsson K, Lundqvist AJ, Strimfors M. 2009. Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development. Drug Dev. Ind. Pharm. 35: 1479-1486.
53. Singh B, Saxena A, Nigam AK, Ganesan K, Pandey P. 2009. Impregnated silica nanoparticles for the reactive removal of sulphur mustard from solutions. J. Hazard. Mater. 161: 933-940.
54. Soto K, Garza KM, Murr LE. 2007. Cytotoxic effects of aggregated nanomaterials. Acta Biomater. 3: 351-358.
55. Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Chang HK, Lee JH, Cho MH, Kelmann BJ, Yu IJ. 2009. Subchronic inhalation toxicity of silver nanoparticles. Toxicol. Sci. 108: 452-461.
56. Teeguarden J, Gupta A, Escobar P, Jackson M. 2008. Toxicology steps up to nanotechnology safety. RD Mag. 50: 28-29.
57. Tu C, Ma X, Pantazis P, Kauzlarich SM, Louie AY. 2010. Paramagnetic, silicon quantum dots for magnetic resonance and two-photon imaging of macrophages. J. Am. Chem. Soc. 132: 2016-2023.
58. Van Der Zande M, Vandebriel RJ, Van Doren E, Kramer E, Herrera Rivera Z, Serrano-Rojero CS, Gremmer ER, Mast J, Peters RJB, Hollman PCH, Hendriksen PJM, Marvin HJP, Peijnenburg AACM, Bouwmeester H. 2012. Distribution, elimination and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 6: 7427-7442.
59. Vandebriel RJ, Tonk EC, de la Fonteyne-Blankestijn LJ, Gremmer ER, Verharen HW, van der Ven LT, van Loveren H, de Jong WH. 2014. Immunotoxicity of silver nanoparticles in an intravenous 28-day repeated-dose toxicity study in rats. Part. Fibre Toxicol. 11: 21.
60. 4 nanoparticles in mice. Int. J. Nanomedicine 5: 861-866.
61. Warheit DB. 2001. Inhaled amorphous silica particulates: what do we know about their toxicological profiles? J. Environ. Pathol. Toxicol. Oncol. 20: 133-141.
62. Wijnhoven SWP, Peijnenburg WJGM, Herberts CA, Hagens WI, Oomen AG, Eugens A, Roszek B, Bisschops J, Gosens I, Van De Meent D, Dekkers S, De EHW, Jong WH, van Zijverden M, Sips AJAM, Geertsma RE. 2009. Nano-silver - a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 3: 109-138.
63. Wittmaack K. 2007. In search of the relevant parameter for quantifying lung inflammatory response to nanoparticle exposure: particle number, surface area, or what? Environ. Health Perspect. 115: 187-194.
64. Xu Y, Wang N, Yu Y, Li Y, Li YB, Yu YB, Zhou XQ, Sun ZW. 2014. Exposure to silica nanoparticles causes reversible damage of the spermatogenic process in mice. PLoS One 9: e101572.
65. Yu T, Malugin A, Ghandehari H. 2011. The impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 5: 5717-5728.
66. Zhang FF, Wan Q, Li CX, Wang XL, Zhu ZQ, Xian YZ, Jin LT, Yamamoto K. 2004. Simultaneous assay of glucose, lactate, l-glutamate and hypoxanthine levels in a rat striatum using enzyme electrodes based on neutral red-doped silica nanoparticles. Anal. Bioanal. Chem. 380: 637-642.
67. Zhang H, Dunphy DR, Jiang X, Meng H, Sun B, Tarn D, Xue M, Wang X, Lin S, Ji Z, Li R, Garcia FL, Yang J, Kirk ML, Xia T, Zink JI, Nel A, Brinker CJ. 2012. Processing pathway dependence of amorphous silica nanoparticle toxicity: colloidal vs. pyrolytic. J. Am. Chem. Soc. 134: 15790-15804.
68. Zhu MT, Feng WY, Wang B, Wang TC, Gu YQ, Wang M, Wang Y, Ouyang H, Zhao YL, Chai ZF. 2008. Comparative study of pulmonary responses to nanoand submicron-sized ferric oxide in rats. Toxicology 247: 102-111.